Table 37.
Treatment | 1st line | 2nd line | 3rd line | 4th line | Total |
---|---|---|---|---|---|
Sequential | 66/80 (82.5%) | 2/6 (33.3%) | 2/2 (100%) | No data | 70/88 (79.5%) |
PPI-CA | 83/207 (40.1%) | 8/33 (24.2%) | 1/4 (25.0%) | 0/1 (0.0%) | 92/245 (37.7%) |
PPI-CM | 5/25 (25.0%) | 2/17 (11.8%) | 0/3 (0.0%) | No data | 7/45 (15.6%) |
Bismuth Quadruple | 8/13 (61.5%) | 36/67 (53.7%) | 20/31 (64.5%) | 3/6 (50.0%) | 67/117 (57.3%) |
PPI-AL | 1/2 (50.0%) | 2/12 (16.7%) | 10/23 (43.5%) | 4/5 (80.0%) | 17/42 (40.5%) |
Miscellaneous | 5/9 (55.6%) | 6/16 (37.5%) | 6/11 (54.5%) | 2/2 (100%) | 19/38 (50.0%) |
Total | 168/336 (50.0%) | 56/151 (37.9%) | 39/74 (52.7%) | 9/14 (64.3%) |